Loading
Latest filing published 30 May 2008 for Sirtris Pharmaceuticals, Inc., €20k.
No signal scores available.
Peter Elliott is a declared insider of Sirtris Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 29 May 2007 to 27 May 2008.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 30 May 2008 came the latest disclosure, an option exercise for €20k in Sirtris Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations